ADULT T-CELL LEUKEMIA-LYMPHOMA
Clinical trials for ADULT T-CELL LEUKEMIA-LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT T-CELL LEUKEMIA-LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT T-CELL LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to keep cancer at bay after risky transplant
Disease control Recruiting nowThis study is testing if a drug called ruxolitinib can help patients with T-cell lymphoma stay in remission after a stem cell transplant. The drug is taken daily for a year to try to prevent the cancer from coming back and to reduce a dangerous complication where the donor cells …
Matched conditions: ADULT T-CELL LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Five-drug cocktail tested against deadly leukemia variant
Disease control Recruiting nowThis study is testing whether combining five different medications can help control a rare and aggressive form of adult leukemia called ETP-ALL. Researchers want to see if this combination is safe and effective for newly diagnosed patients who haven't received other treatments. T…
Matched conditions: ADULT T-CELL LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New Two-Step transplant aims to save more lives from blood cancers
Disease control Recruiting nowThis study is testing a modified, two-step stem cell transplant procedure designed to be safer. It aims to reduce deaths caused by the transplant treatment itself in patients with various blood cancers and disorders. The trial compares two gentler preparation methods using lower …
Matched conditions: ADULT T-CELL LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC